Arachidonyl trifluoromethyl ketone (ATK) is an analog of arachidonic acid.[1] that inhibits some isoforms of the enzyme phospholipase A2.[2] Specifically it inhibits the 85 kDa cystolic PLA2 (cPLA2).[2]
It has been studied as a neuroprotective agent after spinal cord injury,[2][3] and in animal models of multiple sclerosis.[4]
See also
References
- ^ Street, Ian P.; Lin, Hung Kuei; Laliberte, France; Ghomashchi, Farideh; Wang, Zhaoyin; Perrier, Helene; Tremblay, Nathalie M.; Huang, Zheng; Weech, Philip K.; Gelb, Michael H. (1993). "Slow- and tight-binding inhibitors of the 85-k Da human phospholipase A2". Biochemistry. 32 (23): 5935–5940. doi:10.1021/bi00074a003. PMID 8018213.
- ^ a b c Khan, Mushfiquddin; Shunmugavel, Anandakumar; Dhammu, Tajinder S; Matsuda, Fumiyo; Singh, Avtar K; Singh, Inderjit (2015). "Oral administration of cytosolic PLA2 inhibitor arachidonyl trifluoromethyl ketone ameliorates cauda equina compression injury in rats". Journal of Neuroinflammation. 12: 94. doi:10.1186/s12974-015-0311-y. PMC 4436116. PMID 25971887.
- ^ Huang, Wenlong; Bhavsar, Amar; Ward, Rachael E; Hall, Jodie C.E.; Priestley, John V.; Michael-Titus, Adina T. (2009). "Arachidonyl trifluoromethyl ketone is neuroprotective after spinal cord injury". Journal of Neurotrauma. 26 (8): 1429–1434. doi:10.1089/neu.2008-0835. PMID 19371144.
- ^ Vana, Adam C.; Li, Shihe; Ribeiro, Rachel; Tchantchou, Flaubert; Zhang, Yumin (2011). "Arachidonyl trifluoromethyl ketone ameliorates experimental autoimmune encephalomyelitis via blocking peroxynitrite formation in mouse spinal cord white matter". Experimental Neurology. 231 (1): 45–55. doi:10.1016/j.expneurol.2011.05.014. PMID 21683698. S2CID 8652522.